Coliseo

Head-to-Head Startup Ranking & Discovery

I

Invitris

Bio · Europe · Early-stage

invitris.com ↗

Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.

Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →